Neutrophils loaded with cationic liposomal paclitaxel migrate across the blood/brain barrier to deliver chemotherapeutic nanoparticles in the inflamed post-surgical tumour margin.
References
Van Meir, E. G. et al. CA Cancer J. Clin. 60, 166–193 (2010).
Van Meir, E. G., Sawamura, Y, Diserens, A. C., Hamou, M. F. & de Tribolet, N. Cancer Res. 50, 6683–6688 (1990).
Desbaillets, I., Diserens, A.-C., de Tribolet, N., Hamou, M.-F. & Van Meir, E. G. J. Exp. Med. 186, 1201–1212 (1997).
Osuka, S. & Van Meir, E. G. J. Clin. Invest. 127, 415–426 (2017).
Xue, J. et al. Nat. Nanotech. 12, 692–700 (2017).
Binello, E. & Germano, I. M. Neuro. Oncol. 14, 256–265 (2012).
Aboody, K. S. et al. Sci. Transl. Med. 5, 184ra59 (2013).
Kolaczkowska, E. & Kubes, P. Nat. Rev. Immunol. 13, 159–175 (2013).
Fossati, G. et al. Acta Neuropathol. 98, 349–354 (1999).
Allen, M., Bjerke, M., Edlund, H., Nelander, S. & Westermark, B. Sci. Transl. Med. 8, 354re3 (2016).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Osuka, S., Van Meir, E. Neutrophils traffic in cancer nanodrugs. Nature Nanotech 12, 616–618 (2017). https://doi.org/10.1038/nnano.2017.82
Published:
Issue Date:
DOI: https://doi.org/10.1038/nnano.2017.82
- Springer Nature Limited
This article is cited by
-
CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy
Nature Communications (2023)
-
The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo
Particle and Fibre Toxicology (2018)
-
Cell-based drug delivery systems for biomedical applications
Nano Research (2018)